ETNB
Closed
89bio Inc
9.73
-0.09 (-0.92%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 9.82
Day's Range: 9.45 - 9.92
Send
sign up or login to leave a comment!
When Written:
15.455
89bio Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is BIO89-100, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of non-alcoholic steatohepatitis (NASH) and other liver and metabolic diseases.
The company was founded in 2018 and is headquartered in San Francisco, California. It is publicly traded on the NASDAQ under the ticker symbol "ETNB".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company was founded in 2018 and is headquartered in San Francisco, California. It is publicly traded on the NASDAQ under the ticker symbol "ETNB".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








